Home > Healthcare > Medical Devices > Diagnostic Devices > Molecular Diagnostics Market

Molecular Diagnostics Market Analysis

  • Report ID: GMI434
  • Published Date: Apr 2023
  • Report Format: PDF

Molecular Diagnostics Market Analysis

Global Molecular Diagnostics Market, By Product

To understand key trends  
Download Free Sample
 

Molecular diagnostics market value from PCR technology is estimated to surpass USD 22 billion by 2032. New breakthroughs in target-specific PCR systems are providing higher levels of amplification along with simultaneous detection of pathogen DNA. Additionally, PCR has an extensive range of applications in the space of healthcare and research. The technology is primarily used in the effective management of health problems such as caries, endodontic infections, oral cancer, and periodontal disease.
 

Global Molecular Diagnostics Market, By Technology

To understand key market trends  
Download Free Sample
 

Molecular diagnostics market size from hospitals & clinics is anticipated to exhibit more than 3.5% CAGR between 2023 and 2032. Due to the growing disease burden, the emergence of novel epidemics & pandemics, and the increasing spending on healthcare infrastructure, the network of hospitals & clinics worldwide is set to expand significantly.
 

North America Molecular Diagnostics Market

To understand regional trends  Download Free Sample
 

North America molecular diagnostics market size is slated to exceed USD 15 billion by 2032. North America is predicted to emerge as a hub for molecular diagnostics due to the increasing number of infectious disease outbreaks and the growing geriatric population. As per data from the Centers for Disease Control & Prevention (CDC), respiratory syncytial virus (RSV) infections lead to the hospitalization of more than 60,000-120,000 older adults in the U.S. each year with more than 6,000 deaths.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for molecular diagnostics was worth USD 25 billion in 2022 and is anticipated to record a 3.5% CAGR from 2023-2032.

Hospitals & clinics is anticipated to exhibit a 3.5% CAGR between 2023 and 2032 driven by the increasing R&D collaborations and new research facilities.

North America molecular diagnostics market size is slated to exceed USD 15 billion by 2032 owing to a surge in infectious disease cases and novel outbreaks in the region.

Biocartis, bioMerieux SA., Hologic Inc, Illumina, Inc, Qiagen, Siemens Healthineers, and Sysmex Corporation are some of the leading players in the market.

Molecular Diagnostics Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 445
  • Countries covered: 33
  • Pages: 263
 Download Free Sample